Drug Formulary Review Archives – January 1, 2008
January 1, 2008
View Issues
-
Medication reconciliation improved, adverse events decreased
Research conducted by Temple University Hospital and Temple University School of Pharmacy has found that having a pharmacist make rounds with a medicine team improves the accuracy of medication reconciliation and decreases adverse events due to medication error. -
Inpatient insulin pen use yields patient satisfaction
Researchers at Creighton University Medical Center and the School of Pharmacy and Health Professions have found that using prefilled disposable insulin pens rather than conventional vials and syringes in hospitalized diabetic patients led to greater patient satisfaction and cost savings. -
Reducing medication discrepancies
Using a multidisciplinary medication reconciliation process can reduce the number of medication discrepancies that occur during admission and discharge. -
Health system pharmacists ready for BTC medications
The American Society of Health-System Pharmacists (ASHP) says pharmacists in hospitals and health systems are ready to play an expanded role in patient care and medication therapy if FDA decides to designate certain prescription-only drugs as behind-the-counter (BTC) drugs. -
Pharmacists not required to dispense Plan B
A federal judge suspended controversial Washington State rules that required pharmacies to dispense the Plan B emergency contraceptive. -
ASHP again pushes medication safety changes
Spurred by a medication error involving dangerous doses of heparin administered to the newborn children of actor Dennis Quaid, the American Society of Health-System Pharmacists (ASHP) reiterated calls for systemic changes to help reduce medication errors. -
News Brief
FDA asked Bayer Pharmaceuticals Corp. to suspend marketing of Trasylol®, used to control bleeding during heart surgery, pending detailed review of preliminary results from a Canadian study suggesting an increased risk for death. -
Drug Criteria & Outcomes: "Breaking" update on bisphosphonate use in postmenopausal osteoporosis
It is a well-known fact that as we get older, our bones lose mass and become increasingly weaker. -
Drug Criteria & Outcomes: New FDA Approvals
FDA recently announced these approvals: Novartis' Tasigna® (nilotinib) capsules has been approved by FDA for treating Philadelphia chromosome positive chronic myeloid leukemia in adults.